Skip to main content

Advertisement

Log in

Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Skin involvement in dermatomyositis does not always parallel muscle disease and can be the most active or severe component of the disease, failing to respond to therapeutic interventions that are adequate for myositis and other systemic involvement. This case refers to a resistant paraneoplastic amyopathic dermatomyositis rash which readily resolved with intravenous immunoglobulin (IVIG), practically in the form of monotherapy. This observation gains particular significance considering that IVIG is still regarded as a second-line therapeutic regimen in the treatment of dermatomyositis despite its prevalence in matters of safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Sontheimer RD (2004) Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. Best Pract Res Clin Rheumatol 18:429–462

    PubMed  CAS  Google Scholar 

  2. Santmyire-Rosenberger B, Dugan EM (2003) Skin involvement in dermatomyositis. Curr Opin Rheumatol 15:714–722

    Article  PubMed  Google Scholar 

  3. Seishima M, Shimizu H, Oyama Z (2001) Skin metastasis of breast cancer clinically undistinguished from amyopathic dermatomyositis. Eur J Dermatol 11:131–133

    PubMed  CAS  Google Scholar 

  4. Dourmishev AL, Dourmishev LA (1999) Dermatomyositis and drugs. Adv Exp Med Biol 455:187–191

    PubMed  CAS  Google Scholar 

  5. Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, Dobert N, Diehl M, Kaufmann R, Grunwald F (2003) Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET. Q J Nucl Med 47:85–89

    PubMed  CAS  Google Scholar 

  6. Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, Plotz PH, Miller FW (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med 94:379–387

    Article  PubMed  CAS  Google Scholar 

  7. Christopher-Stine L, Plotz HA (2004) Adult inflammatory myopathies. Best Pract Res Clin Rheumatol 18:331–344

    PubMed  CAS  Google Scholar 

  8. Whallett AJ, Gillott TJ, Klocke R, Coppock JS (1998) A case of refractory adult dermatomyositis. Br J Rheumatol 37:544–545

    Article  PubMed  CAS  Google Scholar 

  9. Dalakas MC (2004) The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther 102:177–193

    Article  PubMed  CAS  Google Scholar 

  10. Gottfried I, Seeber A, Anegg B, Rieger A, Stingl G, Volc-Platzer B (2000) High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels. Eur J Dermatol 10:29–35

    PubMed  CAS  Google Scholar 

  11. Mosca M, Strigini F, Carmignani A, D’Ascanio A, Genazzani AR, Bombardieri S (2005) Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum 53:119–121

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Spyros Aslanidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aslanidis, S., Pyrpasopoulou, A., Kartali, N. et al. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis. Clin Rheumatol 26, 1198–1200 (2007). https://doi.org/10.1007/s10067-006-0337-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0337-8

Keywords

Navigation